Received Sep 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | GJ952 | IM |
Neuralgia; left arm pain; This non-serious case was reported by a other health professional and described the occurrence of neuralgia in a 55-year-old female patient who received Herpes zoster (Shingrix) (batch number GJ952, expiry date 25-APR-2027) for prophylaxis. On 08-AUG-2025, the patient received Shingrix (intramuscular) .5 ml. On 09-AUG-2025, 1 days after receiving Shingrix, the patient experienced neuralgia (Verbatim: Neuralgia) and pain in arm (Verbatim: left arm pain). The outcome of the neuralgia and pain in arm were not resolved. It was unknown if the reporter considered the neuralgia and pain in arm to be related to Shingrix. It was unknown if the company considered the neuralgia and pain in arm to be related to Shingrix. Additional Information: GSK Receipt Date: 05-SEP-2025 Reporter reported that the left arm pain appears to be neuralgia, dermatomal in location got affected. Pain became worse in the last two. The patient had two primary care visits related to that and had required medication management for pain. No rashes were observed.